Buy One Get One free -Llimited Time Offer X
Pramitrem 0.125 Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Parkinson's Disease. Pramitrem 0.125 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Pramitrem 0.125 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Pramitrem 0.125 Tablet have been listed ahead. Such side effects of Pramitrem 0.125 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Pramitrem 0.125 Tablet has a Moderate effect for pregnant women and Severe effect on lactating mothers. Further, the section on Pramitrem 0.125 Tablet related warnings talks about Pramitrem 0.125 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Schizophrenia, Heart Disease, Kidney Disease must refrain from the use of Pramitrem 0.125 Tablet since this can cause severe adverse effects.
Drug interactions for Pramitrem 0.125 Tablet have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Pramitrem 0.125 Tablet is considered not safe while driving, and is not addictive.
Pramitrem 0.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramitrem 0.125 Tablet safe for pregnant women?
Pramitrem may have some side effects during pregnancy. Pregnant women should discontinue the use of Pramitrem, and talk to their doctor, if they notice any discomfort.
Is the use of Pramitrem 0.125 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pramitrem. It should only be taken after medical advice.
What is the effect of Pramitrem 0.125 Tablet on the Kidneys?
Pramitrem has very mild side effects on the kidneys.
What is the effect of Pramitrem 0.125 Tablet on the Liver?
Pramitrem does not damage the liver.
What is the effect of Pramitrem 0.125 Tablet on the Heart?
Pramitrem has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Pramitrem 0.125 Tablet unless your doctor advises you to do so -
Is this Pramitrem 0.125 Tablet habit forming or addictive?
Forming a habit of Pramitrem 0.125 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Pramitrem 0.125 Tablet can make you feel drowsy.
Is it safe?
Pramitrem 0.125 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Pramitrem 0.125 Tablet can help with mental disorders.
Interaction between Food and Pramitrem 0.125 Tablet
Some foods when eaten with Pramitrem 0.125 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Pramitrem 0.125 Tablet
Taking alcohol with Pramitrem 0.125 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431